drugset / Trial / NCT03444831

Buspirone Plus Omeprazole for Functional Dyspepsia

NCT03444831

Phase 4 Completed 70 enrolled Isfahan University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a double-blinded Randomised clinical trial aim to compare buspirone plus omeprazole with placebo plus omeprazole.

Timeline

Start
2016-03-01
Primary completion
2017-03-01
Completion
2017-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Buspirone Small molecule 5 mg
Background Omeprazole Other / unclassified 20 mg

Indications